Obtaining the Campaigns list from the server has failed!
Server response:
CM Ad cahger Server plugin is not active on https://legendarygroup.co/admanager/

Dengue drug enters Phase II clinical trial for COVID-19

Biotech Today — June 5, 2020 in News 6 Likes 196 Views

Sun Pharma has announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug.

The post Dengue drug enters Phase II clinical trial for COVID-19 appeared first on BioTech Times.

Source

About the Author: Biotech Today

Obtaining the Campaigns list from the server has failed!
Server response:
CM Ad cahger Server plugin is not active on https://legendarygroup.co/admanager/

About the Author: Biotech Today

You might like

Emtora to use $16.9M grant to develop treatment for rare genetic disease

Gilead to acquire remaining worldwide rights of breast cancer drug, Trodelvy

World’s first CAR-T for treatment of inflammatory disorders of the central nervous system approved in China

axsome therapeutics’ MDD treatment gets green light from FDA

Krystal Biotech’s gets FDA go-ahead for dystrophic epidermolysis bullosa treatment

How re-engineering antibodies can prevent allergies